by Peter Bracke
(Medical Xpress)—Scientists from UCLA's Jonsson Comprehensive Cancer Center have shown for the first time how a unique protein found in human bone marrow can drive stem cells to repair our blood system after an injury.
The groundbreaking findings provide a roadmap that could help scientists make existing radiation and chemotherapy treatments more effective for people with cancer and other blood-related diseases.
Led by Dr. John Chute, a UCLA professor of hematology and radiation oncology and a member of the Jonsson Cancer Center, the nearly two-year study was published online by the Journal of Clinical Investigation. It will appear later in the journal's print edition.
Millions of cancer patients worldwide currently receive some form of radiation therapy or chemotherapy in hopes of curing the disease, and most suffer damage to their blood system as a result. Current therapeutic regimens are also cyclical, generally requiring a 30-day wait period between treatments to allow the blood system time to heal and repair.
A key to the new study were hematopoietic stem cells, which can change and become any other type of blood cell, such as red or white blood cells. Scientists have long studied hematopoietic stem cells in the lab, seeking to understand how bone marrow regulates and instructs them to regenerate and repair themselves, which helps our bodies to recover after an injury or stress.
In prior research, Chute had discovered that endothelial cells—the cells that make up the lining of blood vessels in our bone marrow—play a key role in telling hematopoietic stem cells how to renew and repair themselves. He theorized that following an injury or another stress to our body, the blood system as a whole benefits as the activity in bone marrow directly drives the stem cells to promote and accelerate recovery.
In the new study, Chute and colleagues built upon their previous studies to identify a new protein called pleiotrophin. They discovered that the protein binds to hematopoietic stem cells, and that it is this process that activates the blood stem cells to stimulate the recovery of our entire blood system.
Chute's team conducted experiments in mouse models to administer pleiotrophin after a normally lethal dose of radiation. They found that hematopoietic stem cells and the blood system recovered faster with pleiotrophin than without it, and in two-thirds of the cases the animal survived. Additionally, they found that when they did the opposite—actually blocking pleiotrophin and thereby preventing it from functioning—the blood stem cells saw no advantage in recovery. This strongly suggests that the protein is key in accelerating recovery of the blood system.
"We have now discovered the mechanism by which pleiotrophin can instruct blood stem cells to regenerate," said Chute, who also is a member of the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research. "By modeling it for potential use in human patients, this opens the door for tremendous therapeutic possibilities."
Chute and his team are currently pursuing a Phase I clinical trial with the goal of accelerated recovery for patients undergoing all types of radiation and chemotherapy as well as lessened delays between treatments.
"With this discovery, we hope to provide the basis for improving outcomes for patients with cancer or other blood-related diseases and who are undergoing highly toxic treatments," said Chute.
Explore further: New insight that 'mega' cells control the growth of blood-producing cells
More information: "Pleiotrophin mediates hematopoietic regeneration via activation of RAS" J Clin Invest. DOI: 10.1172/JCI76838.
Medical Xpress on facebook
Related Stories
Duke research team identifies a potent growth factor for blood stem cells
Oct 23, 2012
Duke Medicine researchers studying the interaction of blood stem cells and the niche where they reside have identified a protein that may be a long-sought growth factor for blood stem cells.
New insight that 'mega' cells control the growth of blood-producing cells
Oct 19, 2014
While megakaryocytes are best known for producing platelets that heal wounds, these "mega" cells found in bone marrow also play a critical role in regulating stem cells according to new research from the ...
Newly identified growth factor promotes stem cell growth, regeneration
Mar 21, 2010
Scientists at Duke University Medical Center have identified a new growth factor that stimulates the expansion and regeneration of hematopoietic (blood-forming) stem cells in culture and in laboratory animals. The discovery, ...
Epidermal growth factor aids stem cell regeneration after radiation damage
Feb 03, 2013
Epidermal growth factor has been found to speed the recovery of blood-making stem cells after exposure to radiation, according to Duke Medicine researchers. The finding could open new options for treating cancer patients ...
Damage control: Recovering from radiation and chemotherapy
Apr 30, 2014
Researchers at the University of California, San Diego School of Medicine report that a protein called beta-catenin plays a critical, and previously unappreciated, role in promoting recovery of stricken hematopoietic ...
Recommended for you
Two Michigan high school students develop screening tools to detect lung and heart disease
4 hours ago
Two Michigan high school students, sisters Ilina and Medha Krishen, have developed screening tools using electronic stethoscopes to detect lung and heart disease. The sisters will present their findings at ...
Paralysed man walks again after breakthrough treatment (Update)
12 hours ago
A paralysed Bulgarian man can walk again after receiving revolutionary treatment in Poland in a breakthrough hailed by one of the British scientists responsible as "more impressive than a man walking on the Moon".
Scientists restore hearing in noise-deafened mice, pointing way to new therapies
13 hours ago
Scientists have restored the hearing of mice partly deafened by noise, using advanced tools to boost the production of a key protein in their ears.
Team untangles the biological effects of blue light
13 hours ago
Blue light can both set the mood and set in motion important biological responses. Researchers at the University of Pennsylvania's School of Medicine and School of Arts and Sciences have teased apart the ...
Mouse model provides new insight in to preeclampsia
14 hours ago
Worldwide, preeclampsia is a leading cause of maternal deaths and preterm births. This serious pregnancy complication results in extremely high blood pressure and organ damage. The onset of preeclampsia is associated with ...
Cytokine therapy enhances natural killer cell functions against tumor cells
14 hours ago
Natural killer (NK) cells are sentinels within the immune system that rapidly respond to and kill diseased cells. NK cells typically target and eliminate cells lacking the surface protein MHC class I. However, many tumor ...
User comments
© Medical Xpress 2011-2014, Science X network
by Peter Bracke
(Medical Xpress)—Scientists from UCLA's Jonsson Comprehensive Cancer Center have shown for the first time how a unique protein found in human bone marrow can drive stem cells to repair our blood system after an injury.
The groundbreaking findings provide a roadmap that could help scientists make existing radiation and chemotherapy treatments more effective for people with cancer and other blood-related diseases.
Led by Dr. John Chute, a UCLA professor of hematology and radiation oncology and a member of the Jonsson Cancer Center, the nearly two-year study was published online by the Journal of Clinical Investigation. It will appear later in the journal's print edition.
Millions of cancer patients worldwide currently receive some form of radiation therapy or chemotherapy in hopes of curing the disease, and most suffer damage to their blood system as a result. Current therapeutic regimens are also cyclical, generally requiring a 30-day wait period between treatments to allow the blood system time to heal and repair.
A key to the new study were hematopoietic stem cells, which can change and become any other type of blood cell, such as red or white blood cells. Scientists have long studied hematopoietic stem cells in the lab, seeking to understand how bone marrow regulates and instructs them to regenerate and repair themselves, which helps our bodies to recover after an injury or stress.
In prior research, Chute had discovered that endothelial cells—the cells that make up the lining of blood vessels in our bone marrow—play a key role in telling hematopoietic stem cells how to renew and repair themselves. He theorized that following an injury or another stress to our body, the blood system as a whole benefits as the activity in bone marrow directly drives the stem cells to promote and accelerate recovery.
In the new study, Chute and colleagues built upon their previous studies to identify a new protein called pleiotrophin. They discovered that the protein binds to hematopoietic stem cells, and that it is this process that activates the blood stem cells to stimulate the recovery of our entire blood system.
Chute's team conducted experiments in mouse models to administer pleiotrophin after a normally lethal dose of radiation. They found that hematopoietic stem cells and the blood system recovered faster with pleiotrophin than without it, and in two-thirds of the cases the animal survived. Additionally, they found that when they did the opposite—actually blocking pleiotrophin and thereby preventing it from functioning—the blood stem cells saw no advantage in recovery. This strongly suggests that the protein is key in accelerating recovery of the blood system.
"We have now discovered the mechanism by which pleiotrophin can instruct blood stem cells to regenerate," said Chute, who also is a member of the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research. "By modeling it for potential use in human patients, this opens the door for tremendous therapeutic possibilities."
Chute and his team are currently pursuing a Phase I clinical trial with the goal of accelerated recovery for patients undergoing all types of radiation and chemotherapy as well as lessened delays between treatments.
"With this discovery, we hope to provide the basis for improving outcomes for patients with cancer or other blood-related diseases and who are undergoing highly toxic treatments," said Chute.
Explore further: New insight that 'mega' cells control the growth of blood-producing cells
More information: "Pleiotrophin mediates hematopoietic regeneration via activation of RAS" J Clin Invest. DOI: 10.1172/JCI76838.
Medical Xpress on facebook
Related Stories
Duke research team identifies a potent growth factor for blood stem cells
Oct 23, 2012
Duke Medicine researchers studying the interaction of blood stem cells and the niche where they reside have identified a protein that may be a long-sought growth factor for blood stem cells.
New insight that 'mega' cells control the growth of blood-producing cells
Oct 19, 2014
While megakaryocytes are best known for producing platelets that heal wounds, these "mega" cells found in bone marrow also play a critical role in regulating stem cells according to new research from the ...
Newly identified growth factor promotes stem cell growth, regeneration
Mar 21, 2010
Scientists at Duke University Medical Center have identified a new growth factor that stimulates the expansion and regeneration of hematopoietic (blood-forming) stem cells in culture and in laboratory animals. The discovery, ...
Epidermal growth factor aids stem cell regeneration after radiation damage
Feb 03, 2013
Epidermal growth factor has been found to speed the recovery of blood-making stem cells after exposure to radiation, according to Duke Medicine researchers. The finding could open new options for treating cancer patients ...
Damage control: Recovering from radiation and chemotherapy
Apr 30, 2014
Researchers at the University of California, San Diego School of Medicine report that a protein called beta-catenin plays a critical, and previously unappreciated, role in promoting recovery of stricken hematopoietic ...
Recommended for you
Two Michigan high school students develop screening tools to detect lung and heart disease
4 hours ago
Two Michigan high school students, sisters Ilina and Medha Krishen, have developed screening tools using electronic stethoscopes to detect lung and heart disease. The sisters will present their findings at ...
Paralysed man walks again after breakthrough treatment (Update)
12 hours ago
A paralysed Bulgarian man can walk again after receiving revolutionary treatment in Poland in a breakthrough hailed by one of the British scientists responsible as "more impressive than a man walking on the Moon".
Scientists restore hearing in noise-deafened mice, pointing way to new therapies
13 hours ago
Scientists have restored the hearing of mice partly deafened by noise, using advanced tools to boost the production of a key protein in their ears.
Team untangles the biological effects of blue light
13 hours ago
Blue light can both set the mood and set in motion important biological responses. Researchers at the University of Pennsylvania's School of Medicine and School of Arts and Sciences have teased apart the ...
Mouse model provides new insight in to preeclampsia
14 hours ago
Worldwide, preeclampsia is a leading cause of maternal deaths and preterm births. This serious pregnancy complication results in extremely high blood pressure and organ damage. The onset of preeclampsia is associated with ...
Cytokine therapy enhances natural killer cell functions against tumor cells
14 hours ago
Natural killer (NK) cells are sentinels within the immune system that rapidly respond to and kill diseased cells. NK cells typically target and eliminate cells lacking the surface protein MHC class I. However, many tumor ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment